Albumin-Based Nanodevices as Drug Carriers

Area of Science:

• Nanomedicine
• Biotechnology
• Materials Science

Background:

• Nanomedicine leverages nanotechnology for enhanced drug delivery systems.
• Protein-based nanoparticles, particularly albumin nanoparticles, are gaining interest for their favorable characteristics.
• Albumin's availability, biocompatibility, biodegradability, and low toxicity make it an ideal drug carrier.

Purpose of the Study:

• To review methods for producing albumin-based nanoparticles.
• To focus on high-energy emulsification techniques like sonication and high-pressure homogenization.
• To discuss the role of surfactants like poloxamers in optimizing nanoparticle properties for intravenous administration.

Main Methods:

• Overview of various production methods for albumin-based nanoparticles.
• Detailed comparison of sonication (acoustic cavitation) and high-pressure homogenization (hydrodynamic cavitation).
• Discussion on the use of poloxamers to improve nanoparticle circulation time and bioavailability.

Main Results:

• High-energy emulsification methods are effective for producing albumin nanoparticles.
• Sonication and high-pressure homogenization offer distinct cavitation mechanisms for nanoparticle formation.
• Poloxamers enhance the in vivo performance of albumin nanoparticles.

Conclusions:

• Albumin-based nanoparticles can be engineered for effective therapeutic applications.
• Surface functionalization enables targeted drug delivery.
• Albumin nanoparticles show significant promise for targeted drug delivery in cancer therapy.